53873-026-00 : NDC 2026 Code

53873-026-00 : Lamivudine ( Epivir )

Additionally :

You can get information about “53873-026-00” NDC code in 53873-026-00 in HTML format

HTML | 53873-026-00 in TXT (Plain Text) format

TXT | 53873-026-00 in PDF (Portable Document Format)

PDF | 53873-026-00 in XML format

XML formats.

NDC Code : 53873-026-00 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "53873-026-00",
    "PackageDescription": "240 mL in 1 BOTTLE (53873-026-00) ",
    "NDC11Code": "53873-0026-00",
    "ProductNDC": "53873-026",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Epivir",
    "ProprietaryNameSuffix": "Hbv",
    "NonProprietaryName": "Lamivudine",
    "DosageFormName": "SOLUTION",
    "RouteName": "ORAL",
    "StartMarketingDate": "19981223",
    "EndMarketingDate": null,
    "MarketingCategoryName": "APPROVED DRUG PRODUCT MANUFACTURED UNDER CONTRACT",
    "ApplicationNumber": "NDA021004",
    "LabelerName": "GlaxoSmithKline Inc",
    "SubstanceName": "LAMIVUDINE",
    "StrengthNumber": "5",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Deprecated",
    "LastUpdate": "2017-12-27",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20181231",
    "StartMarketingDatePackage": null,
    "EndMarketingDatePackage": null,
    "SamplePackage": null
  }
}